• 0
MENU
Cart Details

Re-Xite BT Sublingual tablet

  • Home
  • Re-Xite BT Sublingual tablet

Product Informations: Re-Xite BT Sublingual tablet

Place the tablet under the tongue or between the cheek and gum, and let it dissolve. Do not chew, crush, or swallow the tablet. Re-Xite BT Sublingual tablet may be taken with or without food, but it is better to take it at a fixed time.
Re-Xite BT Sublingual tablet is used in the treatment of nutritional deficiencies. It provides essential nutrients. Re-Xite BT Sublingual tablet should be taken in dosage and duration as advised by the doctor. The dosage should not be exceeded without the consultation of doctor. Inform your doctor if you are taking any other medicines. Inform your doctor if you are pregnant or breastfeeding mother or if you are suffering from liver or kidney disease.
Alcohol : CAUTION

Caution is advised when consuming alcohol with Re

Xite BT Sublingual tablet. Please consult your doctor.

Pregnancy : CONSULT YOUR DOCTOR

Re

Xite BT Sublingual tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Breast feeding : SAFE IF PRESCRIBED

Re

Xite BT Sublingual tablet is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.

Driving : SAFE

Re

Xite BT Sublingual tablet does not usually affect your ability to drive.

Kidney : CONSULT YOUR DOCTOR

There is limited information available on the use of Re

Xite BT Sublingual tablet in patients with kidney disease. Please consult your doctor.

Liver : CONSULT YOUR DOCTOR

There is limited information available on the use of Re

Xite BT Sublingual tablet in patients with liver disease. Please consult your doctor.

FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra


Alternatives and Substitutes


Customer Reviews

No customer reviews yet.

References

FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More

European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More

ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More

Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More



Available options.

Same salt composition: Methylcobalamin (1500mcg)

Test Buy medical disposable face mask
to protect your loved ones